Evidence map›Paper›PMID 38980658›Full record

ReviewCurrent neurology and neuroscience reports2024

Brain Networks, Neurotransmitters and Psychedelics: Towards a Neurochemistry of Self-Awareness.

Daniel C Mograbi, Rafael Rodrigues, Bheatrix Bienemann, Jonathan Huntley

Registry-linked trialAbstract readReview
In one paragraph

Review in Current neurology and neuroscience reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07732166 (Changes in Self-awareness Induced by Psychoactive Substances), which is not on this map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07732166 early_phase1recruitingnot on this mapstarted 2026, after this paper: background citation

Changes in Self-awareness Induced by Psychoactive Substances: an Experimental Study With Psilocybin.

TypeinterventionalSponsorPontifícia Universidade Católica do Rio de JaneiroRan2026 to 2027Enrolled100ConditionsHealthy AdultsArmsPsilocybin (Usona Institute), Niacin 100 mg
3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Daniel C MograbiDepartment of Psychology, Pontifical Catholic University of Rio de Janeiro, Rio de Janeiro, Brazil. daniel.mograbi@kcl.ac.uk.
Rafael RodriguesDepartment of Psychology, Pontifical Catholic University of Rio de Janeiro, Rio de Janeiro, Brazil.
Bheatrix BienemannDepartment of Psychology, Pontifical Catholic University of Rio de Janeiro, Rio de Janeiro, Brazil.
Jonathan HuntleyDivision of Psychiatry, University College London, London, UK.

Funding

Wellcome Trust
6 · The paper itself

Abstract

purpose of reviewSelf-awareness can be defined as the capacity of becoming the object of one's own awareness and, increasingly, it has been the target of scientific inquiry. Self-awareness has important clinical implications, and a better understanding of the neurochemical basis of self-awareness may help clarifying causes and developing interventions for different psychopathological conditions. The current article explores the relationship between neurochemistry and self-awareness, with special attention to the effects of psychedelics. RECENT

findingsThe functioning of self-related networks, such as the default-mode network and the salience network, and how these are influenced by different neurotransmitters is discussed. The impact of psychedelics on self-awareness is reviewed in relation to specific processes, such as interoception, body ownership, agency, metacognition, emotional regulation and autobiographical memory, within a framework based on predictive coding. Improved outcomes in emotional regulation and autobiographical memory have been observed in association with the use of psychedelics, suggesting higher-order self-awareness changes, which can be modulated by relaxation of priors and improved coping mechanisms linked to cognitive flexibility. Alterations in bodily self-awareness are less consistent, being potentially impacted by doses employed, differences in acute/long-term effects and the presence of clinical conditions. Future studies investigating the effects of different molecules in rebalancing connectivity between resting-state networks may lead to novel therapeutic approaches and the refinement of existing treatments.

Indexed as

AwarenessBrainHallucinogensNeurotransmitter AgentsHumansNerve NetHallucinogensNeurotransmitter Agentsagencyemotional regulationInteroceptionLSDmetacognitionpsilocybin

Identifiers

PMID38980658
PMCPMC11258181

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.